HeimTEL1 • FRA
add
Sihuan Pharmaceutical Holdings Group Ltd
Við síðustu lokun
0,064 €
Dagbil
0,064 € - 0,064 €
Árabil
0,056 € - 0,096 €
Markaðsvirði
5,32 ma. HKD
Meðalmagn
67,00
V/H-hlutf.
-
A/V-hlutfall
-
Aðalkauphöll
HKG
Í fréttum
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
| (CNY) | des. 2023info | Breyting á/á |
|---|---|---|
Tekjur | 402,42 m. | — |
Rekstrarkostnaður | 374,48 m. | — |
Nettótekjur | -2,19 m. | — |
Hagnaðarhlutfall | -0,54 | — |
Hagnaður á hvern hlut | — | — |
EBITDA | -64,36 m. | — |
Virkt skatthlutfall | -8,22% | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
| (CNY) | des. 2023info | Breyting á/á |
|---|---|---|
Reiðufé og skammtímafjárfestingar | 4,37 ma. | -8,85% |
Heildareignir | 11,54 ma. | -4,98% |
Heildarskuldir | 6,40 ma. | -1,57% |
Eigið fé alls | 5,14 ma. | — |
Útistandandi hlutabréf | 9,28 ma. | — |
Eiginfjárgengi | 0,13 | — |
Arðsemi eigna | -2,18% | — |
Ávöxtun eigin fjár | -3,93% | — |
Peningaflæði
Breyting á handbæru fé
| (CNY) | des. 2023info | Breyting á/á |
|---|---|---|
Nettótekjur | -2,19 m. | — |
Handbært fé frá rekstri | 85,58 m. | — |
Reiðufé frá fjárfestingum | 34,76 m. | — |
Reiðufé frá fjármögnun | -98,03 m. | — |
Breyting á handbæru fé | 22,32 m. | — |
Frjálst peningaflæði | -109,73 m. | — |
Um
Sihuan Pharmaceutical is a Chinese pharmaceutical manufacturer with headquarters in Beijing and branch office in Haikou, Hainan Province. The main company in the group is the holding company Sihuan Pharmaceutical Holdings Group Ltd, which is listed on the Hong Kong stock market.
Sihuan Pharmaceutical is collaborating with the Academy of Military Medical Science in the development of the drug JK-05, intended for the treatment of Ebola virus disease. The company has been challenged by Fujifilm Holdings Corporation, which has stated that JK-05 infringes its patent rights regarding Avigan. Wikipedia
Framkvæmdastjóri
Stofnsett
2001
Vefsvæði
Starfsfólk
2.872
